Bivatuzumab Biosimilar - Anti-CD44v6 Antibody - Low endotoxin, Azide free (A323324)

Name: Bivatuzumab Biosimilar - Anti-CD44v6 Antibody - Low endotoxin, Azide free
Brand: Antibodies.com
SKU: A323324
Price: 295.0 USD
Availability: InStock

Enlarge Image

$295

Recombinant humanized monoclonal antibody to CD44v6 for ELISA, FACS, Functional Assay and In Vivo.

100% Guarantee

Price Match Guarantee

Delivery

Freight Charges

$40 to United States

Lead Time

7-10 Business Days

Contact Us

Telephone

+1 (314) 370-6046

orders@antibodies.com

Guarantees

100% Quality Guarantee

Price Match Guarantee

Tags:

Recombinant Antibody

Specifications

Name

Bivatuzumab Biosimilar - Anti-CD44v6 Antibody - Low endotoxin, Azide free

Description

Recombinant humanized monoclonal antibody to CD44v6.

Applications

ELISA, FACS, Functional Assay, In Vivo

Reactivity

Human

Host

Humanized

Clonality

Monoclonal

Isotype

IgG1

Light Chains

kappa

Conjugate

Unconjugated

Purification

Protein A affinity chromatography.

Concentration

Reconstitution dependent.

Molecular Weight

This antibody has a predicted MW of 143.22 kDa.

Purity

> 95% (by SDS-PAGE and SEC-HPLC).

Product Form

Lyophilized

Reconstitution

Reconstitute with 100µl of sterile double-distilled water to bring antibody to 1mg/ml concentration. Gently shake to solubilize completely. Do not vortex!

Formulation

Lyophilized from 25mM Histadine, pH 6.2, with 8% Sucrose and 0.01% Tween80.

Storage

Shipped at 4°C. Lyophilized: Store at -20°C to -80°C. Reconstituted: Aliquot and store at -80°C. Product is stable for one year. Avoid freeze/thaw cycles.

Synonyms

CD44, CD44 antigen, CD44 molecule, CD44 molecule (Indian blood group), CD44_HUMAN, CDw44, Cell surface glycoprotein CD44, Chondroitin sulfate proteoglycan 8, CSPG8, ECMR-III, Epican, Extracellular matrix receptor III, GP90 lymphocyte homing/adhesion receptor, HCELL, Hematopoietic cell E and L selectin ligand, Heparan sulfate proteoglycan, Hermes antigen, Homing function and Indian blood group system, HUTCH I, HUTCH-I, Hyaluronate receptor, IN, LHR, MC56, MDU2, MDU3, MIC4, MUTCH I, PGP 1, PGP-1, PGP-I, Pgp1, Phagocytic glycoprotein 1, Phagocytic glycoprotein I, Soluble CD44

Suitable Secondaries

See all Anti-Human IgG Secondaries →

Disclaimer

This product is for research use only. It is not intended for diagnostic or therapeutic use.

Scientific Validation Data (2)

Enlarge Image

Figure 1: SDS-PAGE - Bivatuzumab Biosimilar - Anti-CD44v6 Antibody - Low endotoxin, Azide free (A323324)

SDS-PAGE analysis of Bivatuzumab Biosimilar - Anti-CD44v6 Antibody - Low endotoxin, Azide free (A323324) under reducing (R) conditions confirms that the purity of this antibody is greater than 95%.

Enlarge Image

Figure 2: Bivatuzumab Biosimilar - Anti-CD44v6 Antibody - Low endotoxin, Azide free (A323324)

SEC-HPLC analysis of Bivatuzumab Biosimilar - Anti-CD44v6 Antibody - Low endotoxin, Azide free (A323324) confirms that the purity of this antibody is 98.38%.

Publishing research using Bivatuzumab Biosimilar - Anti-CD44v6 Antibody - Low endotoxin, Azide free (A323324)? Please let us know so that we can list the citation on this page.